Type 2 diabetes therapy may prevent memory loss

The type 2 diabetes combined therapy of GLP-1, GIP and glucagon was found to protect against neurological degeneration in an Alzheimer’s disease mouse model, according to a study published inBrain Research.Independent

Source: Society for Endocrinology - January 2, 2018 Category: Endocrinology Source Type: news